FBT ETF

Screen 3,400+ ETFsFind similar ETFs with lower fees
Leveraged fund≈2xWeights reflect notional exposure via swaps/derivatives and do not sum to 100%.
Net exposure
154.8%
Gross exposure
154.8%
Long
154.8%
Cash & collateral
0.1%
As of Apr 30, 2026
Showing 10 of 31 holdings(as of Apr 30, 2026)
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1HTDCorcept Therapeutics Inc7.70%--••••••••••••••••••••••
2ONCBeiGene Ltd5.18%--••••••••••••••••••••••
3ITCIEURIntra-Cellular Therapies Inc4.67%--••••••••••••••••••••••
4CORTCORT3.99%--••••••••••••••••••••••
5NEONEO3.99%--••••••••••••••••••••••
6VRTXVertex Pharmaceuticals Inc3.98%--••••••••••••••••••••••
7ALKSAlkermes PLC3.95%--••••••••••••••••••••••
8AXSMAXSM3.77%--••••••••••••••••••••••
9ARWRARWR3.73%--••••••••••••••••••••••
10ILMNIllumina Inc3.65%--••••••••••••••••••••••
Want to see all 31 holdings?View All HoldingsPRO

FBT ETF Top Holdings

FBT holdings top 10 positions. The top 10 holdings account for 44.6% of the fund, led by Corcept Therapeutics Inc at 7.7%, BeiGene Ltd at 5.2%, Intra-Cellular Therapies Inc at 4.7%.

FBT portfolio concentration is moderate, with the top 10 representing 44.6% of total assets. The largest sector exposure is Unknown at 154.9%.

FBT sector allocation provides a detailed breakdown. FBT overlap tool shows how holdings compare to other funds in your portfolio.

Showing 10 of 31 holdingsNet exposure: 154.8%
#TickerNameIndustryWeightAllocation
1HTDCorcept Therapeutics IncUnknown7.70%
2ONCBeiGene LtdUnknown5.18%
3ITCIEURIntra-Cellular Therapies IncUnknown4.67%
4CORTCORTUnknown3.99%
5NEONEOUnknown3.99%
6VRTXVertex Pharmaceuticals IncUnknown3.98%
7ALKSAlkermes PLCUnknown3.95%
8AXSMAXSMUnknown3.77%
9ARWRARWRUnknown3.73%
10ILMNIllumina IncUnknown3.65%
Want to see all 31 holdings?

Holdings Distribution

Loading chart...